iCliniq Logo
HomeAnswersDiabetologytype 1 diabetes

What are better ways to control T1D in a 13-year-old boy?

This Premium Q&A, reviewed and published, features a real conversation between an iCliniq user and a physician.

Patient's Query

Hello doctor,

My 13-year-old son was diagnosed with type 1 diabetes three years ago and is on regular insulin therapy. Currently, he uses Insulin Degludec (24 units) as basal Insulin and Insulin Aspart for meal coverage.

Despite this regimen, his glycemic control remains suboptimal, with an HbA1c of 7.6 percent. We are exploring advanced management solutions. His recent labs include C-peptide levels. Could you provide insights on optimizing his diabetes management? Please help.

Thank you.

Hello,

Welcome to icliniq.com.

I read your query and can understand your concern.

It sounds like you are doing everything possible to support your son's diabetes management. Achieving optimal control with type 1 diabetes (a condition where the body does not produce insulin due to autoimmune destruction of insulin-producing cells in the pancreas) can be challenging, and it is essential to work closely with his healthcare team to refine his treatment approach.

An HbA1c (glycated hemoglobin, a measure of long-term blood glucose control) level of 7.6 percent suggests there is still room for improvement in glucose control. The American Diabetes Association (ADA) generally recommends a target HbA1c below 7.0 percent for children and adolescents with type 1 diabetes, depending on individual factors. However, it is also important to consider blood glucose variability, the risk of hypoglycemia (low blood sugar), and your son's overall quality of life when making any adjustments to his treatment plan.

Your son is currently using Insulin Degludec (long-acting Insulin that helps control blood glucose over a 24-hour period) as his basal Insulin and Insulin Aspart (rapid-acting Insulin used around meal times to control blood glucose spikes after eating) for postprandial glucose control. It is possible that his Insulin doses or timing may require some adjustments. Several factors could contribute to his suboptimal glucose control, including:

  1. Insulin resistance or changes in Insulin sensitivity: Growth and puberty can significantly affect insulin sensitivity (the body's ability to use Insulin effectively). If he is experiencing increased Insulin resistance (when the body requires more Insulin to achieve the same effect), his doses may need to be adjusted.
  2. Carbohydrate counting and bolus Insulin timing: Bolus Insulin (rapid-acting Insulin given before meals) should be carefully timed to match his carbohydrate intake. Ensuring that Insulin Aspart is administered at the appropriate time relative to meals can help minimize postprandial (after-meal) glucose spikes.
  3. Continuous glucose monitoring (CGM): If he is not already using a continuous glucose monitor (CGM), this device could provide real-time glucose readings and trends, allowing for more precise Insulin adjustments. CGMs help in identifying nocturnal hypoglycemia (low blood sugar at night) and fluctuations during physical activity.
  4. Exercise and activity level: Physical activity can affect blood glucose levels and Insulin needs. It is important to evaluate how exercise influences his Insulin dosing and adjust accordingly to prevent exercise-induced hypoglycemia (low blood sugar caused by physical activity) or hyperglycemia (high blood sugar).
  5. C-peptide levels: C-peptide is a marker of endogenous (naturally produced) Insulin secretion by the pancreas. Since you mentioned recent C-peptide laboratory results, these could help determine if he still has some residual pancreatic function, which might guide Insulin therapy adjustments.

If you can provide his C-peptide results and any other recent laboratory findings, it may help in considering advanced diabetes management options, such as:

  1. Insulin pump therapy: A pump provides continuous subcutaneous Insulin infusion (CSII), allowing for more precise and adjustable Insulin delivery.

  2. Hybrid closed-loop systems: These systems combine Insulin pumps with CGMs (continuous glucose monitors) and use an algorithm (automated system) to adjust Insulin delivery in response to glucose levels.

Additionally, scheduling a consultation with an endocrinologist (a specialist in hormone-related conditions, including diabetes) or a Certified Diabetes Educator (CDE) could be beneficial in further optimizing his treatment plan. Let me know if you would like a more detailed analysis based on his laboratory results.

I hope this helps.

Revert with the answer to assist further.

Thank you and take care.

Medically reviewed byiCliniq medical review team

Published At March 28, 2025
Reviewed AtMay 15, 2025

Same symptoms don't mean you have the same problem. Consult a doctor now!

Listen to related tracks in our music library

Read answers about:

insulintype 1 diabetes

Ask your health query to a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.